Condition

Ureter Cancer

ClinicalTrials.gov condition label

Clinical trials5

Recruiting3

Common interventions7

Lead sponsors shown4

Clinical trials

5 shown

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing MicrobiomeNCT04625556 · 2022-12-19

Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNANCT04197414 · 2019-12-06

Integrated Cancer Repository for Cancer ResearchNCT02012699 · 2013-11-01

The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNCT01846520 · 2013-10-29

Common interventions

Biomarker Testing (L)DIAGNOSTIC_TEST1 educational interventionOTHER1 Patient Reported Outcomes (P)OTHER1 quality-of-life assessmentPROCEDURE1 questionnaire administrationOTHER1 Systemic Treatment (T)DRUG1 telephone-based interventionBEHAVIORAL1

Leading sponsors

Yonsei University2 City of Hope Medical Center1 Taproot Health1 University of Nebraska1

Trial status mix

RECRUITING3

COMPLETED2

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.